Major psychiatric disorders are associated with dysregulated glutamate homeostasis and deficits in the omega-3 fatty acid docosahexaenoic acid (DHA). This study determined the effects of dietary-induced alterations in brain DHA accrual on cortical glutamate homeostasis in the adult rat brain. Adolescent rats were fed a control diet (n = 20), a n-3 fatty acid-deficient diet (DEF, n = 20), or a fish oil-fortified diet containing preformed DHA (FO, n = 20). In adulthood 1 H MRS scans were performed with voxels in the prefrontal cortex (PFC) and thalamus.
A B S T R A C T
Major psychiatric disorders are associated with dysregulated glutamate homeostasis and deficits in the omega-3 fatty acid docosahexaenoic acid (DHA). This study determined the effects of dietary-induced alterations in brain DHA accrual on cortical glutamate homeostasis in the adult rat brain. Adolescent rats were fed a control diet (n = 20), a n-3 fatty acid-deficient diet (DEF, n = 20), or a fish oil-fortified diet containing preformed DHA (FO, n = 20). In adulthood 1 H MRS scans were performed with voxels in the prefrontal cortex (PFC) and thalamus.
Compared with controls, erythrocyte, PFC, and thalamus DHA levels were significantly lower in DEF rats and significantly higher in FO rats. In the PFC, but not the thalamus, glutamate was significantly elevated in DEF rats compared with controls and FO rats. Glutamine did not differ between groups and the glutamine/glutamate ratio was lower in DEF rats. No differences were observed for markers of excitotoxicity (NAA, GFAP), or astrocyte glutamate transporter (GLAST, GLT-1) or glutamine synthetase expression. Across diet groups, PFC DHA levels were inversely correlated with PFC glutamate levels and positively correlated with GLAST expression. Together these findings demonstrate that rat cortical DHA accrual during adolescence impacts glutamate homeostasis in the adult PFC.
Introduction
Converging evidence indicates that mood and psychotic disorders are associated with abnormalities in glutamate neurotransmission. Postmortem brain studies suggest that patients with psychiatric disorders exhibit altered glutamate transporter and N-methyl-D-aspartate (NMDA) receptor subunit expression (Beneyto et al., 2008; Feyissa et al., 2009; Matute et al., 2005; Rao et al., 2012; Uezato et al., 2009) and glutamate concentrations (Hashimoto et al., 2007) . The non-competitive glutamate NMDA receptor antagonist ketamine has psychotogenic effects (Lahti et al., 1995; Malhotra et al., 1997) , as well as rapid antidepressant effects (McGirr et al., 2015) , and increases cortical glutamine in healthy human subjects (Rowland et al., 2005) and glutamate in the rat PFC (Kim et al., 2011 A separate body of translational evidence has identified a deficiency in omega-3 polyunsaturated fatty acids (n-3 PUFA), including docosahexaenoic acid (DHA), as a potential neurodevelopmental risk factor for psychiatric disorders (McNamara et al., 2015; Tesei et al., 2017) . Meta-analyses indicate that bipolar I disorder (McNamara and Welge, 2016) , MDD (Lin et al., 2010) , and schizophrenia (van der Kemp et al., 2012) are associated with erythrocyte (red blood cell) membrane DHA deficits. DHA is the most abundant n-3 PUFA in the mammalian brain, and erythrocyte and frontal cortex DHA levels are positively correlated in adult humans (Carver et al., 2001) . DHA increases rapidly in the human frontal cortex (Carver et al., 2001 ) and rat brain (Green et al., 1999) during active periods of synaptic maturation, and emerging evidence suggests that DHA is required for the structural and functional maturation of glutamatergic synapses (Cao et al., 2009; Moreira et al., 2010; Yoshida et al., 1997) . Furthermore, astrocytes play a key role in maintaining glutamate homeostasis (Hertz and Zielke, 2004) , and DHA is required for optimal astrocyte maturation (Champeil-Potokar et al., 2004 , 2006 Joardar et al., 2006) and modulates astrocyte glutamate
